Overview

Gender

male

Investor Type

Investment Partner

Rob has been a Managing Director at Redmile since 2008. He has been an equity analyst in the medical 
device industry since 1994. His coverage areas have included, among others, cardiology,
orthopedics, urology, vision care, aesthetic surgery and diabetes. Rob has held positions with Thomas
Wiesel Partners, Prudential Financial and J.P. Morgan Chase & Co. Rob began his career on Wall
Street at S.G. Warburg & Co. (now UBS) where he covered biotechnology and medical device stocks
for three years. Prior to moving to sell-side research, he spent two years with The Wilkerson Group 
(now IBM), a consulting firm specializing in the assessment of the value of the healthcare technologies, 
and two years at Tuck School of Business at Dartmouth College. Rob graduated from Harvard College.